miRNA Infomation | |
---|---|
miRNA name | hsa-miR-3676-3p |
Gene Information | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PIAS4 | |||||||||||||||||||||||||||||||||||||||
Synonyms | PIAS-gamma, PIASY, Piasg, ZMIZ6 | |||||||||||||||||||||||||||||||||||||||
Description | protein inhibitor of activated STAT 4 | |||||||||||||||||||||||||||||||||||||||
Transcript | NM_015897 | |||||||||||||||||||||||||||||||||||||||
Expression | ||||||||||||||||||||||||||||||||||||||||
Putative miRNA Targets on PIAS4 | ||||||||||||||||||||||||||||||||||||||||
3'UTR of PIAS4 (miRNA target sites are highlighted) |
>PIAS4|NM_015897|3'UTR 1 CCCCGGCCGCACACTCGACTTTCCTGGTGCTCACCACGCAGAGGGGCACGGGCCAGCCTCGGGCGCAGAGGGAGGAGTGA 81 CCTTTCTTTTTCTTTTTATTGTCGTTCGTTTTGTTTTTCCACCCTTTTGCCTGGCTCCTGGCACCTGTACCTCTGGACTC 161 TCCTATCGGGGGATTAAAAAAAAAAGTAAAATGACAAAAAAAGATACAAAAAAGAAAAATGAAACAAAAAAGTCAAACTC 241 TTAAAAACAAGGCCGGCCACCCACACAGCCGCCTCCCCGGCTGGAGTCCGAGCCGGGAAGGGGTAGTGGGCGGGAGGGAC 321 CAGGACGCCGCCCCGCGCCCTCCCCTCCGGATGCCCCGCCGCCCGCCGCCCTCTGCCCACGACCATTCCAGCCAGTGCGC 401 GGGGACCCGGGCGGCGGGCGGTGGGGCGCAGCCCCTCTCTGGCGACCACTTTGACGTTTGTCTCTTCCTTTGCTTTTTCT 481 CTGCAAATGCATCCTCGCCCAGAGACCCTCACGCGCCGAGCAGCGAGCGTTTTAGCCGAGAAGCCATGGAGTGGGTTGGG 561 GCGGGGAGGGGCAGTAGGGTGGGGGGATGGGTGGGCAGGATGGGGGTACAGTGGGCGGCTGGGGAGGGTTTAGCCACAGA 641 TGTGTTGTATTTTTTGAAAGTGCAATAATTTGGTATTTTGAAGACCCGGCGTGTGGTCAGGAACCCCCGGGGAAGGCGGG 721 GGCCCAGGGTGCGGCACCGTGTGGCGTGGGGGGGTCTCAGTTTTCTAGCCAGCTACCTCGGTAATTCCAATTCAGGTTAA 801 CTTCCCTACGGAACAGCACAGATGTCCACAGATGTCCACAGCTGCCGCCGCCGCCGCCGCCACCATACCCCGGTCCTTGG 881 GGCATGGGTTGCGGTCGCTTCCCAAGGGGCAGCAGGGACCCCGGCCACCCCGGCTCTCGGTTTGGGTTGATTCCTCTCCT 961 TTTTGCTCTTGGTTTTCCGACGGGTACGAGGCTGGCCCGGCACCCTGTCCCCCGGGAGCCTCACTCTTCCAGCAGGACCA 1041 GACCAGGGGCCTCCTTCCTGTCCCCAGGCGTTCCCGGCCCCTCGCAGGCCCCACCCATGCCCTTGGCCTCAGGGTCCAAC 1121 AACTGGGGGAGCTACCAGGGCTCTGCCTTCAGGAGCCCACAGCTGGGCACCCCCCTTGCCCCCCAGGAGACCGGGGCGCA 1201 GGCGGGGCACCGGCCTCACCTGGTTCTCCAACACCGCTGCCTGCGGTCTGTTTTGCTTTTGTCCTCCCCAGCCCAGAATT 1281 TTCCTTTGTATAAACAGAACTCCTAGTCAGGAAGCAATATCATTTCAGGTCTAAAGAAAGGGACGTGCATCTGGCCGAGG 1361 GCAGTTCAGTCTCACTGCAGAGCCCGCAGCCCGCTGCGCAGCTCGGCCCCTCCCGCCCGCACGGGCAGCTGAAGGCCGCT 1441 GTTTTCTAATATTTGTATTCTAATTTAATTGTTTTTAAAAAATGCAAATAAAAAAGGTCGAGGTGAAGCCAAAAAAAAAA 1521 AAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
|||||||||||||||||||||||||||||||||||||||
DRVs in gene 3'UTRs |
|
|||||||||||||||||||||||||||||||||||||||
SNPs in gene 3'UTRs |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | Flp-In T-REx 293-hAGO1 cells | ||||||
Location of target site | CDS | ||||||
Original Description (Extracted from the article) |
...
Validation of interactions identified by CLASH suppports their reliability.
... - Helwak A; Kudla G; Dudnakova T; Tollervey D, 2013, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Helwak A; Kudla G; Dudnakova T; Tollervey D - Cell, 2013
MicroRNAs (miRNAs) play key roles in gene regulation, but reliable bioinformatic or experimental identification of their targets remains difficult. To provide an unbiased view of human miRNA targets, we developed a technique for ligation and sequencing of miRNA-target RNA duplexes associated with human AGO1. Here, we report data sets of more than 18,000 high-confidence miRNA-mRNA interactions. The binding of most miRNAs includes the 5' seed region, but around 60% of seed interactions are noncanonical, containing bulged or mismatched nucleotides. Moreover, seed interactions are generally accompanied by specific, nonseed base pairing. 18% of miRNA-mRNA interactions involve the miRNA 3' end, with little evidence for 5' contacts, and some of these were functionally validated. Analyses of miRNA:mRNA base pairing showed that miRNA species systematically differ in their target RNA interactions, and strongly overrepresented motifs were found in the interaction sites of several miRNAs. We speculate that these affect the response of RISC to miRNA-target binding.
LinkOut: [PMID: 23622248]
|
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
6 hsa-miR-3676-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT052869 | PIAS4 | protein inhibitor of activated STAT 4 | 1 | 1 | ||||||||
MIRT052870 | DAG1 | dystroglycan 1 | 1 | 1 | ||||||||
MIRT052871 | DYNC1LI2 | dynein cytoplasmic 1 light intermediate chain 2 | 1 | 1 | ||||||||
MIRT052872 | USP7 | ubiquitin specific peptidase 7 | 1 | 1 | ||||||||
MIRT052873 | PGD | phosphogluconate dehydrogenase | 1 | 1 | ||||||||
MIRT052874 | CTC1 | CST telomere replication complex component 1 | 1 | 1 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|